Sharper & Granite LLC Has $865,000 Stock Position in SPDR S&P Biotech ETF $XBI

Sharper & Granite LLC cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.7% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 8,635 shares of the exchange traded fund’s stock after selling 4,013 shares during the quarter. Sharper & Granite LLC’s holdings in SPDR S&P Biotech ETF were worth $865,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of XBI. CWM LLC increased its stake in shares of SPDR S&P Biotech ETF by 4.7% in the 3rd quarter. CWM LLC now owns 13,793 shares of the exchange traded fund’s stock valued at $1,382,000 after acquiring an additional 614 shares in the last quarter. Financial Council LLC acquired a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at about $201,000. Farther Finance Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 6.3% during the third quarter. Farther Finance Advisors LLC now owns 7,530 shares of the exchange traded fund’s stock valued at $755,000 after purchasing an additional 448 shares during the period. Sloy Dahl & Holst LLC bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $201,000. Finally, Baldwin Wealth Partners LLC MA acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at about $205,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $126.30 on Friday. The business has a 50-day simple moving average of $116.73 and a 200 day simple moving average of $99.78. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $126.50. The firm has a market capitalization of $7.67 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.